Skip to search.
 TSX Down 0.05% TSX Ventures Up 0.04%

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
3.44 Down 0.06(1.71%) 3:59PM EDT
|After Hours : 3.45 Up 0.01 (0.29%) 4:01PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:3.50
Open:3.51
Bid:3.44 x 1700
Ask:3.45 x 2600
1y Target Est:6.50
Beta:2.08
Earnings Date:Aug 3 - Aug 7 (Est.)
Day's Range:3.41 - 3.58
52wk Range:1.56 - 5.20
Volume:488,264
Avg Vol (3m):1,009,450
Market Cap:303.22M
P/E (ttm):N/A
EPS (ttm):-0.99
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
RIGLDown 1.71%303.22M
AMGNDown 1.91%119.65B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):29.58
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.83
Quarterly EPS Est (Jun-15) :-0.21
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune diseases, immuno-oncology related diseases, and muscle disord... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback